14Indexed trials
mesh condition
Spasm
Intelligence
Spasm intelligence: 14 indexed trials, 1 recruiting studies, 13 sponsors across 6 countries.
1Recruiting
13Sponsors
6Countries
Leading sponsors
Rhodes Pharmaceuticals, L.P.20 recruiting
Centre Hospitalier Universitaire de Nice10 recruiting
Dalhousie University10 recruiting
GlaxoSmithKline10 recruiting
Laboratorios Ordesa10 recruiting
McMaster University11 recruiting
National Institute of Mental Health (NIMH)10 recruiting
Pharmasoft10 recruiting
Seattle Children's Hospital10 recruiting
Shire10 recruiting
Tel-Aviv Sourasky Medical Center10 recruiting
Assistance Publique - Hôpitaux de Paris10 recruiting
Geographic activity
United States6trials
France3trials
Canada1trials
Israel1trials
Russia1trials
Spain1trials
Leading interventions
Behavioral Parent Training1trials
Digital Cognitive Training1trials
Digital Non-cognitive Training Intervention1trials
Driving test on a simulator1trials
Extended-release bupropion hydrochloride1trials
Heteroquestionnaires1trials
Maintenance Wakefulness Test1trials
Medium Chain Triglycerides1trials
Methylphenidate1trials
Methylphenidate Hydrochloride Extended Release Capsule1trials
Methylphenidate Hydrochloride Extended Release Capsules1trials
Mexidol1trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.